A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.
Clinical trial NCT04435652 · UNKNOWN
Trial details
- NCT number
- NCT04435652
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2022-04-30
- Enrollment
- 492
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.